Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Benjamin T Dake"'
Autor:
Henry Yim Wu, Francisco J Quintana, Andre Pires da Cunha, Benjamin T Dake, Thomas Koeglsperger, Sarah C Starossom, Howard L Weiner
Publikováno v:
PLoS ONE, Vol 6, Iss 8, p e23618 (2011)
Type 1 regulatory T (Tr1) cells, characterized by the secretion of high levels of the anti-inflammatory cytokine interleukin-10 (IL-10), play an important role in the regulation of autoimmune diseases and transplantation. However, effective strategie
Externí odkaz:
https://doaj.org/article/bb678c61496945a39d237f82ec6f77a1
Autor:
Hunter Gillies, Murali M. Chakinala, Benjamin T. Dake, Jeremy P. Feldman, Marius M. Hoeper, Marc Humbert, Zhi‐Cheng Jing, Jonathan Langley, Vallerie V. McLaughlin, Ralph W. Niven, Stephan Rosenkranz, Xiaosha Zhang, Nicholas S. Hill
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 1, Pp n/a-n/a (2024)
Abstract AV‐101 (imatinib) powder for inhalation, an investigational dry powder inhaled formulation of imatinib designed to target the underlying pathobiology of pulmonary arterial hypertension, was generally well tolerated in healthy adults in a p
Externí odkaz:
https://doaj.org/article/6cca6181d66a4a5aadc281acfa6b68ed
Autor:
Hunter Gillies, Ralph Niven, Benjamin T. Dake, Murali M. Chakinala, Jeremy P. Feldman, Nicholas S. Hill, Marius M. Hoeper, Marc Humbert, Vallerie V. McLaughlin, Martin Kankam
Publikováno v:
ERJ Open Research, Vol 9, Iss 2 (2023)
Background Oral imatinib has been shown to be effective, but poorly tolerated, in patients with advanced pulmonary arterial hypertension (PAH). To maintain efficacy while improving tolerability, AV-101, a dry powder inhaled formulation of imatinib, w
Externí odkaz:
https://doaj.org/article/6e8ff00f40604cb1bb338a1660e59c87
Autor:
Philip N. Tsichlis, Charlotte Kuperwasser, Elizabeth McNiel, Philip W. Hinds, Stephen P. Naber, Zhu Shen, Scott A. Ezell, Benjamin T. Dake, Ania Wronski, Patricia Keller, Ioannis Sanidas, Parthena Foltopoulou, Filippos Kottakis
PDF file - 154KB, Table S1. Cell lines, media. Table S2. Pre-miRs and anti-miRs. Table S3. Primers. Table S4. Antibodies. Table S5. Clinical characteristics of the tumor-samples used in Figure 7.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49026bfd552452332c868793aa3d0399
https://doi.org/10.1158/0008-5472.22401611.v1
https://doi.org/10.1158/0008-5472.22401611.v1
Autor:
Philip N. Tsichlis, Charlotte Kuperwasser, Elizabeth McNiel, Philip W. Hinds, Stephen P. Naber, Zhu Shen, Scott A. Ezell, Benjamin T. Dake, Ania Wronski, Patricia Keller, Ioannis Sanidas, Parthena Foltopoulou, Filippos Kottakis
PDF file - 3801KB, The knockdown of NDY1/KDM2B is not rescued by exogenous EZH2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62e3d2b28892221a0f625290a592ef2f
https://doi.org/10.1158/0008-5472.22401617.v1
https://doi.org/10.1158/0008-5472.22401617.v1
Autor:
Philip N. Tsichlis, Charlotte Kuperwasser, Elizabeth McNiel, Philip W. Hinds, Stephen P. Naber, Zhu Shen, Scott A. Ezell, Benjamin T. Dake, Ania Wronski, Patricia Keller, Ioannis Sanidas, Parthena Foltopoulou, Filippos Kottakis
PDF file - 3478KB, Knockdown of NDY1/KDM2B promotes differentiation of human mammary adenocarcinoma cell lines in culture.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a66a4626fa648b7892aa3e315848933
https://doi.org/10.1158/0008-5472.22401626
https://doi.org/10.1158/0008-5472.22401626
Autor:
Philip N. Tsichlis, Charlotte Kuperwasser, Elizabeth McNiel, Philip W. Hinds, Stephen P. Naber, Zhu Shen, Scott A. Ezell, Benjamin T. Dake, Ania Wronski, Patricia Keller, Ioannis Sanidas, Parthena Foltopoulou, Filippos Kottakis
PDF file - 867KB, NDY1/KDM2B is required for cellular transformation by RAS-G12V.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c1abb3f57542b938565c8a315b6a230
https://doi.org/10.1158/0008-5472.22401635
https://doi.org/10.1158/0008-5472.22401635
Autor:
Philip N. Tsichlis, Charlotte Kuperwasser, Elizabeth McNiel, Philip W. Hinds, Stephen P. Naber, Zhu Shen, Scott A. Ezell, Benjamin T. Dake, Ania Wronski, Patricia Keller, Ioannis Sanidas, Parthena Foltopoulou, Filippos Kottakis
PDF file - 91KB, The knockdown of NDY1/KDM2B is not rescued by exogenous BMI1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a8bf69ae72d0491fb0fb016b4598026
https://doi.org/10.1158/0008-5472.22401614
https://doi.org/10.1158/0008-5472.22401614
Autor:
Philip N. Tsichlis, Charlotte Kuperwasser, Elizabeth McNiel, Philip W. Hinds, Stephen P. Naber, Zhu Shen, Scott A. Ezell, Benjamin T. Dake, Ania Wronski, Patricia Keller, Ioannis Sanidas, Parthena Foltopoulou, Filippos Kottakis
PDF file - 139KB, The knockdown of NDY1/KDM2B interferes with the replating efficiency of mammospheres from both basal and luminal mammary adenocarcinoma cell lines.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aa13c85309398050a1da6e9ae136735
https://doi.org/10.1158/0008-5472.22401629.v1
https://doi.org/10.1158/0008-5472.22401629.v1
Autor:
Philip N. Tsichlis, Charlotte Kuperwasser, Elizabeth McNiel, Philip W. Hinds, Stephen P. Naber, Zhu Shen, Scott A. Ezell, Benjamin T. Dake, Ania Wronski, Patricia Keller, Ioannis Sanidas, Parthena Foltopoulou, Filippos Kottakis
PDF file - 59KB, The knockdown of NDY1/KDM2B suppresses the activity of the Wnt pathway, despite the upregulation of Wnt1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68b8a6a992098e8876c1ceb303f4393d
https://doi.org/10.1158/0008-5472.22401620.v1
https://doi.org/10.1158/0008-5472.22401620.v1